Yang, Andrew C. http://orcid.org/0000-0002-6756-4746
Stevens, Marc Y.
Chen, Michelle B.
Lee, Davis P.
Stähli, Daniel
Gate, David http://orcid.org/0000-0003-0481-9657
Contrepois, Kévin http://orcid.org/0000-0001-9678-5161
Chen, Winnie
Iram, Tal
Zhang, Lichao
Vest, Ryan T.
Chaney, Aisling
Lehallier, Benoit
Olsson, Niclas http://orcid.org/0000-0002-9746-0542
du Bois, Haley
Hsieh, Ryan
Cropper, Haley C.
Berdnik, Daniela http://orcid.org/0000-0001-7452-3785
Li, Lulin
Wang, Elizabeth Y.
Traber, Gavin M. http://orcid.org/0000-0003-3494-9196
Bertozzi, Carolyn R.
Luo, Jian http://orcid.org/0000-0002-2064-8467
Snyder, Michael P. http://orcid.org/0000-0003-0784-7987
Elias, Joshua E.
Quake, Stephen R. http://orcid.org/0000-0002-1613-0809
James, Michelle L.
Wyss-Coray, Tony http://orcid.org/0000-0001-5893-0831
Article History
Received: 20 June 2019
Accepted: 21 May 2020
First Online: 1 July 2020
Competing interests
: C.R.B. is a co-founder and Scientific Advisory Board member of Palleon Pharmaceuticals, Enable Bioscience, InterVenn Bio and Redwood Bioscience (a subsidiary of Catalent), and a member of the Board of Directors of Eli Lilly and Company. T.W.-C. is a co-founder and scientific advisor of Alkahest Inc. T.W.-C. and A.C.Y. are co-inventors on a patent application related to the work published in this paper. N.O. is affiliated with Calico Life Sciences and has no financial interests to declare.